Mitochondria and intermediary metabolism are central to health and disease, yet many of us learn a simplified version of this complex science. To develop expertise in metabolism research at Yale School of Medicine (YSM), Richard Kibbey, MD, PhD, professor of medicine (endocrinology and metabolism), created the Program for Mitochondrial Biology and Intermediary Metabolism (MBIM).
Mitochondria are key to the regulation of tissue function, such as insulin secretion, glucose production, nerve transmission, muscular contraction, and inflammation as well as cancer cell growth, Kibbey explains. The term “intermediary” refers to the compounds—the chemical metabolites—that are going through and transformed by the metabolic pathways.
There are a lot of misconceptions about how to measure mitochondrial function and metabolism and the meaning of various observations, Kibbey notes. “The educational component of MBIM will promote a deeper understanding of the fundamental mechanisms of mitochondrial metabolism and chemical biology, and how to design, perform, and interpret studies,” he said.
The goal of the program, which Kibbey launched in early 2023, is to catalyze collaboration, provide education, promote publications, offer innovative technologies, and help investigators obtain funding.